Accelerated gastric emptying of glucose in Zucker type 2 diabetic rats: Role in postprandial hyperglycaemia

Diabetologia

Volumn 40, Issue 2, 1997, Pages 136-142

  Green, G M ^a   Guan, D ^a   Schwartz, J G ^a   Phillips, W T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cholecystokinin; Gastric emptying; Glycaemic control; Secretin; Trypsin inhibitor

Indexed keywords

CAMOSTAT; CAMOSTAT MESILATE; CHOLECYSTOKININ OCTAPEPTIDE; GLUCOSE; SECRETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GAMMA SCINTIGRAPHY; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING;

ANIMALS; CHOLECYSTOKININ; DIABETES MELLITUS, TYPE 2; GABEXATE; GASTRIC EMPTYING; GLUCOSE; GUANIDINES; HYPERGLYCEMIA; MALE; POSTPRANDIAL PERIOD; RATS; RATS, ZUCKER; SECRETIN; TRYPSIN INHIBITORS;

EID: 0031026319     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050654     Document Type: Article

References (32)

1. Phillips WT, Schwartz JG, McMahan CA (1992) Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 33: 1496-1500
2. Loo FD, Palmer DW, Soergel KH, Kalbfleisch JH, Wood CM (1984) Gastric emptying in patients with diabetes mellitus. Gastroenterology 86: 485-494
3. Liddle RA, Morita ET, Conrad CK, Williams JA (1986) Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 77: 992-996
4. Phillips WT, Schwartz JG, McMahan CA (1993) Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying. Dig Dis Sci 38: 51-58
5. Liddle RA, Rushakoff RJ, Morita ET, Beccaria L, Carter JD, Goldfine ID (1988) Physiological role for cholecystokinin in reducing postprandial hyperglycaemia in humans. J Clin Invest 81: 1675-1681
6. m glucose transporters in noninsulin-dependent diabetes. Science 250: 546-549
7. Unger RH (1991) Diabetic hyperglycaemia: link to impaired glucose transport in pancreatic β cells. Science 251: 1200-1205
8. Miyasaka K, Nakamura R, Kitani K (1989) Effects of trypsin inhibitor (camostat) on pancreas and CCK release in young and old female rats. J Gerontol 44:M136-M140
9. Watanabe S, Takeuchi T, Chey WY (1992) Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats. Gastroenterology 102: 621-628
10. Green T, Dimaline R, Peikin S, Dockray GJ (1988) Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat. Am J Physiol 255:G685-G689
11. Elashoff JD, Meyer JH, Reedy TJ (1982) Analysis of gastric emptying data. Gastroenterology 83: 1306-1312
12. Nowak TV, Johnson CP, Kalbfleisch JH, et al. (1995) Highly variable gastric emptying in patients with insulin-dependent diabetes mellitus. Gut 37: 23-29
13. Nowak TV, Roza AM, Weisbruch JP, Brosnan MR (1994) Accelerated gastric emptying in diabetic rodents: effect of insulin treatment and pancreas transplantation. J Lab Clin Med 123: 110-116
14. Granneman JG, Stricker EM (1984) Food intake and gastric emptying in rats with streptozotocin-induced diabetes. Am J Physiol 247:R1054-R1061
15. Raybould HE, Holzer H (1993) Secretin inhibits gastric emptying in rats via a capsaicin-sensitive vagal afferent pathway. Eur J Pharmacol 250: 165-167
16. Murthy SN, Ganiban G (1988) Effect of the secretin family of peptides on gastric emptying and small intestinal transit in rats. Peptides 9: 583-588
17. Rushakoff RA, Goldfine ID, Beccaria LJ, Mathur A, Brand RJ, Liddle RA (1993) Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycaemia. J Clin Endocrinol Metab 76: 489-493
18. Glasbrenner B, Dominguez-Munoz E, Riepl RL, Vetsi A, Malfertheiner P (1995) Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Dig Dis Sci 40: 406-411
19. Guan D, Phillips WT, Schwartz JG, Paul E, Rehfeld J, Green GM (1995) Plasma CCK and secretin levels are elevated in type II diabetes. Gastroenterology 108:A973 (Abstract)
20. Baile CA, McLaughlin CL, Moos AB (1982) Effects of CCK on gastrointestinal function in lean and obese Zucker rats. Peptides 3: 619-622
21. McLaughlin CL, Peikin SR, Baile CA (1982) Decreased pancreatic exocrine response to cholecystokinin in Zucker obese rats. Am J Physiol 242:G612-G619
22. McLaughlin CL, Baile CA (1980) Decreased sensitivity of Zucker obese rats to the putative satiety agent cholecystokinin. Physiol Behav 25: 543-548
23. Green GM (1994) Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases. In: Reeve JR, Eysselein VJ, Solomon TE, Go VLW (eds) Cholecystokinin, vol 713. New York Academy of Sciences, New York, pp 167-179
24. Lu Y, Owyang C (1995) Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway. Am J Physiol 268:G1012-G1016
25. Raybould HE, Tache Y (1988) Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol 255:G242-G246
26. Gainsborough N, Maskrey VL, Nelson ML, et al. (1993) The association of age with gastric emptying. Age and Aging 22: 37-40
27. Maerz LL, Sankaran H, Scharpf SJ, Deveney CW (1994) Effect of caloric content and composition of a liquid meal on gastric emptying in the rat. Am J Physiol 267:R1163-R1167
28. Young AA, Gedulin B, Vine W, Percy A, Rink TJ (1995) Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38: 642-648
29. Hiramatsu S, Inoue K, Sako Y, Umeda F, Nawata H (1994) Insulin treatment improves relative hypersecretion of amylin to insulin in rats with non-insulin-dependent diabetes mellitus induced by neonatal streptozocin injection. Metabolism 43: 766-770
30. Butler PC, Chou J, Carter WB, et al. (1990) Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756
31. Schwartz JG, Green GM, Guan D, Phillips WT (1994) Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels following a liquid meal in type II diabetic patients. Diabetes Care 17: 255-262
32. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41: 1575-1586